Status:

COMPLETED

Confronting Unequal Eye Care in Pennsylvania

Lead Sponsor:

Wills Eye

Collaborating Sponsors:

Thomas Jefferson University

Temple University

Conditions:

Diabetic Retinopathy

Diabetes Mellitus, Type 2

Eligibility:

All Genders

21+ years

Phase:

NA

Brief Summary

Pt. 1 Diabetic retinopathy is a common eye condition among diabetic adults and can lead to severe vision impairment and even blindness. African Americans are more likely to have vision loss from diabe...

Detailed Description

An additional aim was added to this project, examining the effect of a telephone intervention on eye care adherence and comparing the efficacy of the intervention to usual care and automated telephone...

Eligibility Criteria

Inclusion

  • Pt. 1
  • African-American race (self-identified)
  • Age ≥ 65 years
  • Type II Diabetes Mellitus (physician diagnosis) for at least 1 year
  • No medical documentation of a DFE by an ophthalmologist or an optometrist within the past 12 months
  • Self-report of no DFE within the past 12 months

Exclusion

  • Cognitive Impairment (Mini-Mental Status Examination ≤ 24)
  • Current clinically significant psychiatric disorder other than depression
  • Current medical disorder that limits life expectancy (≤ 12 months) or need for dialysis
  • Hearing impairment that precludes research participation
  • Pt. 2
  • Inclusion Criteria:
  • Glaucoma (physician diagnosis)
  • Scheduled for a follow-up appointment that meets the American Academy of Ophthalmology (AAO) follow-up guidelines
  • Attended the Wills Eye Glaucoma Clinic from September 1, 2012 to October 31, 2013
  • Age ≥ 21 years old
  • Able to understand and speak English

Key Trial Info

Start Date :

October 1 2010

Trial Type :

INTERVENTIONAL

Allocation :

ACTUAL

End Date :

May 1 2014

Estimated Enrollment :

206 Patients enrolled

Trial Details

Trial ID

NCT01179555

Start Date

October 1 2010

End Date

May 1 2014

Last Update

April 10 2017

Active Locations (3)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (3 locations)

1

Thomas Jefferson University

Philadelphia, Pennsylvania, United States, 19107

2

Wills Eye Health System

Philadelphia, Pennsylvania, United States, 19107

3

Temple University

Philadelphia, Pennsylvania, United States, 19140